China NMPA Inspection - Xinfutang Pharmacy, Longli County, Guizhou Province - August 10, 2017

The State Food and Drug Administration (SFDA) recently conducted unannounced inspections of ten retail pharmacies across Liaoning, Hunan, and Guizhou provinces, revealing serious regulatory violations. Companies such as Xinfutang, Pingyi, and Dongyang Feiyu Pharmacies were among those cited. Common violations included the sale of unpackaged, unlabeled, or expired medications, and products lacking essential details like approval numbers or manufacturer information. A significant issue was the inability to provide purchase invoices or supplier qualifications, indicating illegal sourcing of drugs. Some pharmacies operated beyond their approved business scope, selling restricted items or unapproved traditional Chinese medicinal herbs, while others faced suspicions of prescription fraud and improper storage. These breaches severely contravene the *Drug Administration Law of the People's Republic of China*, its *Implementation Regulations*, and the *Good Supply Practice for Pharmaceutical Products*. Consequently, local food and drug regulatory departments have revoked GSP certifications, confiscated illegally sourced medicines, initiated investigations, and will pursue legal action, including criminal prosecution for cases involving unapproved or counterfeit drugs. The SFDA mandates that pharmacies enhance self-management and compliance, and local administrations intensify supervision and enforce severe penalties to uphold drug quality and public safety.